FHIR IG analytics| Package | de.medizininformatikinitiative.kerndatensatz.molgen |
| Resource Type | Task |
| Id | Task-mii-exa-molgen-medikationsempfehlung-fgfr2-fusion.json |
| FHIR Version | R4 |
No resources found
No resources found
Note: links and images are rebased to the (stated) source
English
Generated Narrative: Task mii-exa-molgen-medikationsempfehlung-fgfr2-fusion
Profiles: MII PR MolGen Medikationsempfehlung version: 2027.0.0-ballot.1, Medication Recommendation version: 3.0.0
basedOn: ServiceRequest Molecular genetic test (procedure)
status: Requested
intent: proposal
code: Hochselektive FGFR-Inhibitor-Therapie
for: Anonymous Patient Female, DoB: 1964-05 ( pseudonymized (use: usual, ))
reasonReference: Observation Therapeutic Implication
German
Generated Narrative: Task mii-exa-molgen-medikationsempfehlung-fgfr2-fusion
Profiles: MII PR MolGen Medikationsempfehlung version: 2027.0.0-ballot.1, Medication Recommendation version: 3.0.0
basedOn: ServiceRequest Molecular genetic test (procedure)
status: Requested
intent: proposal
code: Hochselektive FGFR-Inhibitor-Therapie
for: Anonymous Patient Female, DoB: 1964-05 ( pseudonymized (use: usual, ))
reasonReference: Observation Therapeutic Implication
{
"resourceType": "Task",
"id": "mii-exa-molgen-medikationsempfehlung-fgfr2-fusion",
"meta": {
"profile": [
"https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/StructureDefinition/medikationsempfehlung|2027.0.0-ballot.1",
"http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/medication-recommendation|3.0.0"
]
},
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"basedOn": [
{
"reference": "ServiceRequest/mii-exa-molgen-anforderung-fgfr2-fusion"
}
],
"status": "requested",
"intent": "proposal",
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "LA26421-0",
"display": "Consider alternative medication"
}
],
"text": "Hochselektive FGFR-Inhibitor-Therapie"
},
"for": {
"reference": "Patient/mii-exa-molgen-patient-fgfr2-fusion"
},
"reasonReference": {
"reference": "Observation/mii-exa-molgen-therapeutische-implikation-fgfr2-fusion"
}
}